Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

AOP ORPHAN PHARMACEUTICALS GMBH

  • FDA Approval
  • Nov. 25, 2024, 12:21 UTC
  • 51
  • 0 comments

FDA approve LANDIOLOL

Comment Full text

UNICHEM

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 48
  • 0 comments

FDA approve ETODOLAC

Comment Full text

STERISCIENCE

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 50
  • 0 comments

FDA approve SUMATRIPTAN SUCCINATE

Comment Full text

LEADING

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 53
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

UMEDICA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 45
  • 0 comments

FDA approve DICLOFENAC POTASSIUM

Comment Full text

MARKSANS PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 51
  • 0 comments

FDA approve LORATADINE

Comment Full text

SENORES PHARMS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 51
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

NEXUS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 53
  • 0 comments

FDA approve METHYLENE BLUE

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 48
  • 0 comments

FDA approve MOMETASONE FUROATE

Comment Full text

GENENTECH INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 44
  • 0 comments

FDA approve PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF

Comment Full text
  • Previous
  • 241
  • 242
  • 243
  • 244
  • 245
  • Next

Search

News categories

  • Technical Exchange News(10600)
  • Event(2007)
  • SEC News(184713)
  • FDA Approval(9847)
  • Company Report(721)
  • Business News(122402)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin